Bluejay Diagnostics, Inc. (BJDX)

Price & Market Data

Price: $1.92

Daily Change: -$0.03 / 1.56%

Daily Range: $1.83 - $1.97

Market Cap: $1,986,652

Daily Volume: 35,562

Performance Metrics

1 Week: 11.05%

1 Month: -4.50%

3 Months: -4.98%

6 Months: -62.98%

1 Year: -74.19%

YTD: -31.69%

About Bluejay Diagnostics, Inc. (BJDX)

Get a comprehensive snapshot of Bluejay Diagnostics, Inc. (BJDX). Current price: 1.92, daily change: -$0.03 / 1.56%. Market cap: 1,986,652. Performance YTD, 1-week, and 3-month.

Company Details

Employees: 6

Sector: Health technology

Industry: Medical specialties

Country: United States

Details

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Selected stocks

GlucoTrack, Inc. (GCTK)

AlTi Global, Inc. (ALTI)

Anfield Energy Inc. (AEC)

GreenPower Motor Company Inc. (GP)

Savara, Inc. (SVRA)